A convertible bond of LivaNova, a medical technology company that develops and markets cardiovascular and neuromodulation devices, including heart-lung machines and vagus nerve stimulation therapy.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Steve Cohen / Point72 | — | New buy | 1,259 | $65,960 | 0.0% |
| Howard Marks / Oaktree | 69 | Added +51% | 15,085,000 | $16,252,986 | 0.3% |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-07-02.